Global Vaccine Adjuvants Market Report 2019: Market Size, Analysis, Trends, Key Players, Strategies (2017-2026)
Some of the factors such as the high occurrence of zoonotic and infectious syndromes, growing geriatric population and rising usage of adjuvants in vaccine are fueling the market growth.
GAITHERSBURG, Maryland, Sept. 19, 2019 /PRNewswire/ -- According to Stratistics MRC, the Global Vaccine Adjuvants Market is accounted for $460.21 million in 2017 and is expected to reach $1,330.25 million by 2026 growing at a CAGR of 12.5% from 2017 to 2026.
Some of the key players in Vaccine Adjuvants market include Viscogel AB, Vaxliant, Vaxine Pty Ltd., Sigma Aldrich (Merck KGaA), Sergeant Adjuvants, OZ Biosciences, Novavax, Inc., Novartis/CSL, MVP Laboratories, Inc., Kineta, Inc., Invivogen, GSK, CureVac AG, CSL Limited, Avanti Polar Lipids, Aphios Corp., Agenus, Inc., Adjuvatis and Adjuvance Technologies, Inc.
Some of the factors such as the high occurrence of zoonotic and infectious syndromes, growing geriatric population and rising usage of adjuvants in vaccine are fueling the market growth. However, factors such as cost of adjuvant development and side effects of adjuvants are hampering the market growth. The rising usage of synthetic vaccines and recombinant sub-unit are acting as an opportunity for market growth in the coming years.
Request for sample here: https://www.strategymrc.com/report/vaccine-adjuvants-market/request-sample
Adjuvants are fundamentally compounds that improve the body's immunogenic reaction against antigens. As a result, these are majorly added to vaccines to increase their capability to influence long-term protection and safety against any kind of viruses. Currently, MF59 and aluminium salts are the only adjuvants which are viable for human usage. There have been a lot of developments done on the antigen discovery over the past decade which has enhanced the vaccine development process.
Amongst Route of Administration, Intramuscular Route segment is driven by owing to rapidly rising geriatric population and vaccines for enhanced immunization are propelling the growth of this segment. These include vaccines for HPV, influenza, meningitis, etc.
Access the complete report at: https://www.strategymrc.com/report/vaccine-adjuvants-market
By geography, North America region has dominated the market during the forecast period due to factors such as higher adoption, greater knowledge about regular vaccination and presence of major market players, coupled with higher healthcare expenditure.
Make an inquiry at: https://www.strategymrc.com/report/vaccine-adjuvants-market
Products Covered:
- Pathogen Components
- Particulate Adjuvants
- Combination Adjuvants
- Adjuvant Emulsions
- Saponin
- Other Types
Disease Types Covered:
- Cancer
- Infectious Diseases
- Other Disease Types
Types Covered:
- Virus-like Particles
- Tensoactive Adjuvants
- Organic Adjuvants
- Mineral Salt-based Adjuvants
- Liposomes
- Emulsions
- Carbohydrates Adjuvants
- Bacteria-derived Adjuvants
- Other Types
Mechanism of Actions Covered:
- Vehicle Adjuvants
- Carriers
- Active Immunostimulants
Route of Administrations Covered:
- Subcutaneous Route
- Oral Route
- Intranasal Route
- Intramuscular Route
- Intradermal Route
- Other Route of Administrations
Applications Covered:
- Veterinary Vaccine Adjuvants
- Human Vaccine Adjuvants
End Users Covered:
- Research Institutes
- Pharmaceutical Companies
- Contract Manufacturing Organization
- Commercial
- Pediatric
- Adults
- Other End Users
Regions Covered:
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- Italy
- UK
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
- South America
- Argentina
- Brazil
- Chile
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- Qatar
- South Africa
- Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 9 years of all the mentioned segments, sub-segments, and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Follow us on Twitter: https://twitter.com/StratisticsMRC
Follow us on LinkedIn at: https://www.linkedin.com/company/stratistics-market-research-consulting-pvt-ltd?trk=mini-profile
About Stratistics MRC
We offer a wide spectrum of research and consulting services with in-depth knowledge of different industries. We are known for customized research services, consulting services, and Full-Time Equivalent (FTE) services in the research world. We explore market trends and draw our insights with valid assessments and analytical views. We use advanced techniques and tools among the quantitative and qualitative methodologies to identify the market trends.
Our research reports and publications are routed to help our clients to design their business models and enhance their business growth in the competitive market scenario. We have a strong team with hand-picked consultants including project managers, implementers, industry experts, researchers, research evaluators and analysts with years of experience in delivering the complex projects.
Contact Info:
Name: James Lamb
Email: [email protected]
Organization: Stratistics Market Research Consulting Pvt Ltd
Phone: +1-301-202-5929
Website: https://www.strategymrc.com
View original content:http://www.prnewswire.com/news-releases/global-vaccine-adjuvants-market-report-2019-market-size-analysis-trends-key-players-strategies-2017-2026-300921571.html
SOURCE Stratistics Market Research Consulting Pvt Ltd
